MCP
RPTX

Militia Capital Partners’s Repare Therapeutics RPTX Stock Holding History

Militia Capital Partners’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$310K Hold
119,176
– – 0.12% 155
2025
Q3 		$210K Hold
119,176
– – 0.1% 160
2025
Q2 		$166K Buy
+119,176
New +$155K 0.08% 154

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Militia Capital Partners's RPTX Position: Q4 2025 in Review

Militia Capital Partners held its Repare Therapeutics (RPTX) position steady in Q4 2025 at 119,176 shares worth $310K. The position accounts for 0.12% of the portfolio, ranked #155.

Militia Capital Partners first reported a position in RPTX in Q2 2025 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold RPTX as of Q4 2025.

  • Militia Capital Partners held 119,176 shares of Repare Therapeutics worth $310K as of Q4 2025.
  • Militia Capital Partners left its Repare Therapeutics share count unchanged in Q4 2025.
  • Repare Therapeutics made up 0.12% of Militia Capital Partners's portfolio in Q4 2025, its #155 holding.
  • Militia Capital Partners first reported a position in Repare Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 46 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.